Needles Market Needles Market: Business Planning Research, Reviews & Comparison of Alternatives

Needles
are integral part of healthcare functions. Needles provide advantage
over other routes of administration such as quick release of the drug
in bodily fluids and instant relief for the patients. It has various
applications ranging from surgical use to blood collection to drug
administration. Needles such as safety needles are increasingly used
in order to avoid needle stick injuries and infection. Needles such
as pen needles are used by diabetic patients who need daily dose of
insulin which is injected subcutaneously.
Market
Dynamics
Major
factor driving growth of the needles market is increasing demand for
vaccines, globally to prevent various diseases such as measles,
rubella and hepatitis B. According to World Health Organization (WHO)
2018, globally around 86% of infants are vaccinated against 26
diseases, however, 19.5 million children unvaccinated leading to
death of 2-3 million children each year. Human papilloma virus causes
cervical cancer and around 280,000 women died from cervical cancer in
2015 globally, which led to introduction of vaccine to prevent
cervical cancer, in turn positively affecting needles market.
Introduction of stringent guidelines for safe injection practices is
expected to aid in growth of the needles market. For instance, WHO
issued safe injection practices and guidelines in 2010, for its
member country. Also, Association of Professionals in Infection
Control and Epidemiology in the U.S. issued updated guidelines in
2016 to prevent spread of infectious disease through unsafe injection
practices.
High
prevalence of chronic diseases worldwide is projected to fuel growth
of the needles market
Several
factors are associated with increasing adoption of needles worldwide.
One of the major factors is high prevalence of chronic disease across
the world, which is propelling demand for needles. According to the
World Health Organization (WHO), in 2017, non-communicable diseases
such as cancer, diabetes, cardiovascular diseases, and lung diseases
accounted for around 70% death worldwide, which was majorly from
middle and low income economies. Furthermore, chronic diseases are
expected to account for around 75% of all deaths worldwide by 2020.
Therefore, this is expected to aid in market growth, as needle is an
integral part of chronic disease treatment. For instance, according
to Diabetic Atlas by International Diabetes Federation (IDF), 2017,
diabetes affected around 425 million people worldwide. Patients
suffering from diabetes require daily administration of insulin with
continuous glucose monitoring, which in turn is propelling demand for
pen needles. Furthermore, the U.S. majorly invest in treatment of
diabetes and cancer, annually. For instance, around US$ 377 Billion
are invested, which account for 52% of the total diabetes expenditure
worldwide, according to the IDF report 2017. Also, according to World
Cancer Research Organization, 2014 report, cancer incidence in the
U.S. is one of highest at 328 per 100,000, which is expected to
propel growth of the needles market in this region.
Request
For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1331
Growing
geriatric population worldwide to drive growth of the global needles
market
Rising
geriatric population is expected to drive growth of the needles
market. As per World Population Prospect, 2017 Revision report by
United Nations in 2017, there were 962 million people, under the
geriatric category (people aged 60 years and above). By 2030, this is
projected to be 1.4 billion increasing at an annual rate of 3%.
Geriatric people require frequent hospitalizations due to
aging-associated diseases such as heart disease, stroke, diabetes and
falling injuries. In certain cases, surgery is required which leads
to hospitalization. This is expected to aid in growth of the market.
Asia Pacific has a geriatric population of 547 million people, which
is expected to reach 900 million geriatric population by 2025.
Therefore, manufacturers could focus on expanding in this region.
Also, stringent regulations related to safe injection practices by
various governments is expected to propel demand for safety needles,
in order to reduce chances of contamination from blood borne
pathogens, for instance according to report published by WHO in 2014,
up to 1.7 million people were infected with hepatitis B virus, up to
315 000 with hepatitis C virus and as many as 33 800 with HIV through
an unsafe injection.
Some
of the key players operating in the global needles market are Becton,
Dickinson and Company, Medtronic plc, Hamilton Company, Stryker
Corporation, Terumo Corporation, B. Braun Melsungen AG, Boston
Scientific Corporation, Nipro Medical Corporation, Novo Nordisk A/s,
Thermo Fisher Scientific, and Smiths Medical.
About
Coherent Market Insights
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us
Mr.
Shah
Coherent
Market Insights
1001
4th Ave, #3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
Comments
Post a Comment